Isobe, H.; Shimizu, F.; Ieda, T.; Nakamura, S.; Takazawa, N.; Suetsugu, H.; Kajino, K.; Hirai, S.; Hirano, H.; Yuzawa, K.;
et al. Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain. Biomedicines 2025, 13, 174.
https://doi.org/10.3390/biomedicines13010174
AMA Style
Isobe H, Shimizu F, Ieda T, Nakamura S, Takazawa N, Suetsugu H, Kajino K, Hirai S, Hirano H, Yuzawa K,
et al. Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain. Biomedicines. 2025; 13(1):174.
https://doi.org/10.3390/biomedicines13010174
Chicago/Turabian Style
Isobe, Hideyuki, Fumitaka Shimizu, Takeshi Ieda, So Nakamura, Naoko Takazawa, Hanna Suetsugu, Kazunori Kajino, Shu Hirai, Hisashi Hirano, Katsuhito Yuzawa,
and et al. 2025. "Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain" Biomedicines 13, no. 1: 174.
https://doi.org/10.3390/biomedicines13010174
APA Style
Isobe, H., Shimizu, F., Ieda, T., Nakamura, S., Takazawa, N., Suetsugu, H., Kajino, K., Hirai, S., Hirano, H., Yuzawa, K., & Horie, S.
(2025). Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain. Biomedicines, 13(1), 174.
https://doi.org/10.3390/biomedicines13010174
